Compounding pharmacies in Massachusetts with FDA records

Which compounding pharmacies in Massachusetts have FDA records?

GLP-1 Ledger lists 4 compounding pharmacies and outsourcing facilities in Massachusetts named in FDA records: 1 on FDA’s registered outsourcing facility list (updated Nov 6, 2026) and 4 with an entry on FDA’s compounding inspections and actions page (current as of Oct 22, 2026), 1 of them with at least one FDA warning letter listed there. State board of pharmacy records for Massachusetts are not checked: the board’s website refused automated requests, and this index does not work around blocks.

The list covers pharmacies FDA names on its 503B list or its compounding inspections and actions page, for all drugs, not only GLP-1s. The Massachusetts board of pharmacy licenses pharmacies and keeps its own records, which this index has not checked.

Advanced Compounding Solutions (New England Life Care, Inc.)Woburn503ANo matching record foundNot checked11May 16, 2023
Fresenius Kabi Compounding LLC dba Fagron Sterile ServicesCanton503BRecord foundNot checked20Nov 5, 2025
Hopkinton Drug, Inc.Hopkinton503ANo matching record foundNot checked10Mar 7, 2022
New England Compounding CenterFramingham503ANo matching record foundNot checked00Jul 17, 2019

FDA 503B list column: “Record found” means FDA’s registered outsourcing facility list names the pharmacy at this location; “No matching record found” means no row matched by name and location when this index last checked. Form 483, warning letter and latest action columns count what FDA’s compounding inspections and actions page lists; a 503B list row’s own inspection columns are on its facility page. State license column: “License found” means the state board file lists a license with the same name and city; “No exact match” means it does not, which is not a finding that the pharmacy is unlicensed; “Not checked” means this index does not read that board’s license records.

Other states

Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Maine, Maryland, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin

This page restates FDA’s lists. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.